Accepted at 11:02 p.m. Oct, 31, 2023 by dollajas
Author: dina
Related Note: 1487815375221
Rationale for change

better format

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Low/HighYield::3-HighYield-temporary #AK_Step1_v12::#AMBOSS #AK_Step2_v12::#AMBOSS::f1akTj #AK_Step1_v12::#Bootcamp::Musculoskeletal::03_Rheumatologic_Disease::02_Systemic_Lupus_Erythematosus #AK_Step1_v12::#SketchyPath::11_Immunology::01_Autoimmune_&_Amyloidosis::01_Autoimmune_Disease:_Overview_&_Systemic_Lupus_Erythematosus_(SLE) #AK_Step1_v12::#AMBOSS::f1akTj #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::03_Hypercoagulable_Disorders_DDx #AK_Step2_v12::#SketchyOBGYN::06_Reproductive_Endocrinology_&_Infertility::02_Infertility::01_APLS_&_Recurrent_Pregnancy_Loss #AK_Step2_v12::#AMBOSS::0B0ezR #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Immunology_+_General_Pathology::Pathoma_Chapter_2_(Inflammation) #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::05_Thrombophilias #AK_Step1_v12::#OME::04_Organ_Systems::02_Musculoskeletal::02_Rheumatology::04_Other_Rheumatologic_Conditions #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::03_Coagulopathies_&_Platelet_Disorders::05_Acquired_&_Inherited_Thrombosis_Syndromes #AK_Step1_v12::#Bootcamp::Musculoskeletal::03_Rheumatologic_Disease::04_Antiphospholipid_Syndrome #PANCE::EOR::IM #AK_Step1_v12::#OME::04_Organ_Systems::02_Musculoskeletal::02_Rheumatology::03_Polyarticular_Arthropathies #AK_Step1_v12::#B&B::13_Immunology::04_Autoimmune_Disorders::01_Systemic_Lupus_Erythematosus #AK_Step1_v12::#Pathoma::02_Inflammation::04_Autoimmune_Disorders::2 #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::02_Pathology::25_Systemic_lupus_erythematosus #AK_Step2_v12::#FirstAid::07_Hematology::02_Hypercoagulable_States::04_Antiphospholipid_Syndrome #AK_Step2_v12::#AMBOSS::6GajZm #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::02_Musculoskeletal::02_Rheumatology::03_Polyarticular_Arthropathies #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::17_Hypercoagulable_States #AK_Step2_v12::#AMBOSS::KGaUZm #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::03_Hypercoagulable_States #AK_Step2_v12::#SketchyIM::07_Rheumatology::07_Systemic_Diseases::02_Systemic_Lupus_Erythematosus_SOAP #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::02_Pathology::26_Antiphospholipid_syndrome #AK_Step1_v12::#FirstAid::02_Immunology::03_Immune_Responses::15_Autoantibodies #AK_Step2_v12::#B&B::09_MSK::01_General::04_Systemic_Lupus_Erythematosus #AK_Step1_v12::#NinjaNerd::09_Hematology::02_Pathology::19_Platelet_Disorders #AK_Step2_v12::#FirstAid::08_MSK::01_Whole_Body::17_Systemic_Lupus_Erythematosus #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::03_Hypercoagulable_States